"Improving cancer outcomes is one of the major issues in our lifetime. We can only address it if we harness the input of so many different experts and so many different fields. The way that the cancer center is set up, it’s doing that."
Andrea L. “Andi” Wolfe, a hands-on philanthropist and former small business owner, has been serving in volunteer leadership roles throughout Southeastern Michigan, nationally, and globally for more than 40 years.
Science is advancing quickly to develop even more fertility preserving options for women diagnosed with cancer or other conditions that threaten their ability to have a baby. Here are two approaches that, while not yet widely available, illustrate where the science is headed and paint an even more optimistic picture of the future of fertility preservation.
Obstetric gynecologist Molly Moravek and Rogel Cancer Center fertility preservation coordinator, Erin Ellman, talk about the importance of fertility preservation for those of child bearing age who have cancer.
MRelay 2019, an annual fundraising event on the University of Michigan campus to support the American Cancer Society and its commitment to lifesaving research, treatment and care of cancer patients, is April 6!
Researchers from the University of Michigan Rogel Cancer Center will attend the American Association for Cancer Research (AACR) Annual Meeting from Friday, March 29 through Wednesday, April 4, 2019. Many of them plan to participate in poster sessions and oral presentations. Below is a schedule of who is presenting, when, where and on what topic.
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
MENU
